paper present initial data prospective study lung aging heterozygotes alpha deficiency using design cases included NUMBER heterozygotes alpha deficiency protease inhibitor phenotypes mz ms selected parents children homozygous alpha deficiency identified statewide newborn screening program NUMBER NUMBER heterozygotes NUMBER yr age control subjects selected random sample working population participating longitudinal study lung aging using NUMBER match control subjects cases matching age sex ethnic origin smoking using respiratory symptom questionnaire spirometry n2 test significant difference heterozygotes control subjects terms respiratory symptoms pulmonary function data conclude NUMBER yr age heterozygous phenotype pi mz ms risk factor impairment pulmonary function cross sectional NUMBER antitrypsin case control NUMBER antitrypsin NUMBER antitrypsin single breath